Inventor · disambiguated record
Onur Boyman
Also filed as: BOYMAN ONUR
3 granted patents·7 pending applications·0 citations·filing 2007–2023
49Inventor score
Top patents by PatentIndex Score
10 records- 0172US2024368266A1Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereofUNIV ZUERICH·Filed 2023·Application pending·0 cites
- 0265US11851484B2Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereofUNIV ZUERICH·Filed 2020·Granted Dec 26, 2023·0 cites·21 claims
- 0355US2021230269A1Immune-stimulating monoclonal antibodies against human interleukin-2NOVARTIS AG·Filed 2020·Application pending·0 cites
- 0454US10889643B2Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereofNOVARTIS AG·Filed 2017·Granted Jan 12, 2021·0 cites·17 claims
- 0547US2023303680A1A cd25-biased anti-il-2 antibodyUNIV ZUERICH·Filed 2021·Application pending·0 cites
- 0645US2022047718A1Nanoparticle-Based Therapy of Inflammatory DisordersMIDATECH LTD·Filed 2019·Application pending·0 cites
- 0741US10894828B2Immune-stimulating monoclonal antibodies against human interleukin-2BOYMAN ONUR·Filed 2015·Granted Jan 19, 2021·0 cites·25 claims
- 0839US2010310501A1Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian SubjectBOYMAN ONUR·Filed 2007·Application pending·0 cites
- 0934US2013142755A1Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian SubjectBOYMAN ONUR·Filed 2012·Application pending·0 cites
- 1031US2019016796A1Combination therapy comprising a superagonistic antibody against interleukin-2 and a checkpoint blockade agentUNIV ZUERICH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Onur Boyman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →